Methods for treating inflammatory skin conditions
AssigneeCSL Innovation Pty Ltd
InventorsCatherine Mary OWCZAREK, Angel Francisco LOPEZ, Ho Kwok YIP, Damon John TUMES
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to methods of treating inflammatory skin conditions using compounds that bind to CD131 and inhibit GM-CSF and IL-5 signaling. The present disclosure also relates to compounds for use in the treatment or prevention of an inflammatory skin condition, as well as the use of such compounds in the manufacture of medicaments for the treatment or prevention of inflammatory skin conditions.
Claims21
A method for treating an inflammatory skin condition in a subject, the method comprising administering a compound that binds to CD131 and neutralizes signaling by granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin (IL) 5 to the subject.
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.